These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10756773)

  • 1. [Hypersensitivity reactions to antilipemic drugs].
    Palel G; Coman EA; Siniţchi G; Petrovanu R; Stafie C
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):66-9. PubMed ID: 10756773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported multiple drug reactions: clinical profile and results of challenge testing.
    Ramam M; Bhat R; Jindal S; Kumar U; Sharma VK; Sagar R; Chadda RK
    Indian J Dermatol Venereol Leprol; 2010; 76(4):382-6. PubMed ID: 20657119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous drug eruption secondary to nicotinic acid/laropiprant.
    Ho SA; Aw DC
    Ann Acad Med Singap; 2012 Mar; 41(3):134-5. PubMed ID: 22538743
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antilipemic drug-induced skin manifestations].
    Proksch E
    Hautarzt; 1995 Feb; 46(2):76-80. PubMed ID: 7706076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug eruptions: approaching the diagnosis of drug-induced skin diseases.
    Nigen S; Knowles SR; Shear NH
    J Drugs Dermatol; 2003 Jun; 2(3):278-99. PubMed ID: 12848112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Skin and hair].
    Briner VA
    Schweiz Med Wochenschr; 1996 Apr; 126(14):549-58. PubMed ID: 8668968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases.
    Hassani A; Ponvert C; Karila C; Le Bourgeois M; De Blic J; Scheinmann P
    Eur J Dermatol; 2008; 18(5):561-5. PubMed ID: 18693161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skin reactions attributed to the use of bromhexine].
    van Riemsdijk MM; van der Klauw MM; Stricker BH; Herings RM
    Ned Tijdschr Geneeskd; 1994 Dec; 138(49):2446-8. PubMed ID: 7997301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antilipemic therapy in dyslipidemias in obese non-insulin-dependent diabetics (ONIDDM)].
    Palel G; Coman A; Petrovanu R; Ungureanu D; Cojocaru M
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):120-2. PubMed ID: 10756782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antilipemic agents, hypothyroidism, and rhabdomyolysis].
    Pía Iglesias G; Garrido Sanjuán JA; González González C; Sesma Sánchez P
    Rev Clin Esp; 2000 Apr; 200(4):236-7. PubMed ID: 10857417
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drugs and drug combinations responsible for cutaneomucosal reactions].
    Dechy H
    Rev Stomatol Chir Maxillofac; 1976; 77(5):757-64. PubMed ID: 137515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins.
    Barbaud A; Trechot P; Weber-Muller F; Ulrich G; Commun N; Schmutz JL
    Contact Dermatitis; 2004 Jan; 50(1):22-6. PubMed ID: 15059099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin manifestations caused by the medicamentous allergy to the first antituberculous drugs].
    Horvat M; Jakasa D; Radielović P
    Tuberkuloza; 1966; 18(1-3):90-4. PubMed ID: 16296073
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.
    Lammintausta K; Kortekangas-Savolainen O
    Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's your assessment? Niacin.
    Bielan B
    Dermatol Nurs; 2006 Jun; 18(3):244. PubMed ID: 16856677
    [No Abstract]   [Full Text] [Related]  

  • 17. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation.
    Wilkin JK; Hammond JJ; Kirkendall WM
    Arch Dermatol; 1980 Aug; 116(8):902-5. PubMed ID: 6250496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danger signs in drug hypersensitivity.
    Scherer K; Bircher AJ
    Med Clin North Am; 2010 Jul; 94(4):681-9, xv-x. PubMed ID: 20609857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutaneous adverse drug reactions: enhanced imputation score by skin testing].
    Choquet-Kastylevsky G; Vial T; Santolaria N; Nageotte A; Faure M; Claudy A; Descotes J
    Ann Dermatol Venereol; 2001 Apr; 128(4):507-11. PubMed ID: 11395648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases.
    Lockhart SM; Rathbun RC; Stephens JR; Baker DL; Drevets DA; Greenfield RA; Salvaggio MR; Vincent S
    AIDS; 2007 Jun; 21(10):1370-3. PubMed ID: 17545718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.